REGENXBIO Inc.
RGNX
$9.66
$0.293.10%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 22.71M | -90.05M | -67.15M | -61.94M | -70.87M |
| Total Depreciation and Amortization | 3.76M | 3.86M | 3.87M | 3.89M | 3.91M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 14.58M | 11.51M | 12.79M | 12.47M | 10.09M |
| Change in Net Operating Assets | -103.28M | -1.50M | -1.80M | -10.37M | 7.54M |
| Cash from Operations | -62.24M | -76.19M | -52.29M | -55.96M | -49.34M |
| Capital Expenditure | -760.00K | -1.24M | -508.00K | -491.00K | -391.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 66.69M | 71.82M | 38.05M | 42.78M | -140.05M |
| Cash from Investing | 65.93M | 70.59M | 37.54M | 42.29M | -140.44M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 19.55M | 794.00K | 90.00K | 741.00K | 78.00K |
| Repurchase of Common Stock | 0.00 | -828.00K | 0.00 | -123.00K | 0.00 |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1.98M | -13.61M | -9.67M | -7.70M | 139.15M |
| Cash from Financing | 17.57M | -13.64M | -9.58M | -7.08M | 139.23M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 21.26M | -19.24M | -24.34M | -20.76M | -50.55M |